SCHEMBL9714604

SCHEMBL9714604

N#CCc1ccc(CCl)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.43
CYP3A4 P08684 1/20 0.43
KMT2A Q03164 1/20 0.38
ESR1 P03372 2/20 0.35
ESR2 Q92731 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
NPC1 O15118 2/20 0.33
FLT3 P36888 1/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
ABCB1 P08183 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
TNF P01375 1/20 0.32
ENPP2 Q13822 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
PIK3CA P42336 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23591286 0.89 TDP1 (0.50) TDP1CYP3A4KMT2AESR1ESR2
SCHEMBL9714810 0.85 ENPP2 (0.42) TDP1CYP3A4KMT2AESR1ESR2
SCHEMBL22871613 0.82 CYP3A4 (0.57) TDP1CYP3A4KMT2AESR1ESR2
SCHEMBL2939551 0.82 CA1 (0.41) TDP1KMT2ACA1CA2NPC1
SCHEMBL9714610 0.82 MAOB (0.46) TDP1CYP3A4KMT2ACA2NPC1
Hydrochloric Acid SCHEMBL5143704 0.81 CYP3A4 (0.55) TDP1CYP3A4KMT2AESR1ESR2
(Chloromethyl)Benzene SCHEMBL304085 0.80 CYP3A4 (0.60) TDP1CYP3A4KMT2AESR1ESR2
SCHEMBL5115366 0.78 TDP1 (0.57) TDP1CYP3A4KMT2AESR1ESR2
SCHEMBL6201046 0.77 TDP1 (0.50) TDP1CYP3A4ESR1ESR2CA1
SCHEMBL5076043 0.77 TDP1 (0.55) TDP1CYP3A4KMT2AESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5166210-A QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1992-11-24 US disclosed
US-5028615-A Treatment of hypersensitivity RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1991-07-02 US disclosed
US-4920133-A Quinoline derivatives and use thereof as antagonists of leukotriene D4 RORER PHARMACEUTICAL CORP. (US) 1990-04-24 US disclosed